Category: Mergers & AcquisitionsSyndicate content

Tengion is on the auction block

September 29, 2014 by Alexander Soule

Tengion puts itself and its organ regeneration technology on the auction block, hiring Jefferies LLC to explore "strategic alternatives."

Tengion, TNGN, Jefferies, organ regeneration, kidney

YYmeta

Tengion (NSDQ:TNGN) said it's hired Jefferies to assess "all strategic alternatives," corporate shorthand for putting the Winston-Salem, N.C.-based company and its organ regeneration technology on the auction block.

New U.S. tax rules may lead Medtronic to redo inversion deal

September 29, 2014 by MassDevice

Medtronic is likely to attempt a renegotiation of its $43 billion acquisition of Covidien now that the U.S. Treasury Dept. has changed the rules on tax inversion deals.

New U.S. tax rules may lead Medtronic to redo inversion deal

Ackman threatens to sue Allergan again over potential Salix deal

September 24, 2014 by MassDevice

Billionaire William Ackman's Pershing Square Capital Management threatens to sue Allergan if it goes ahead with a deal to buy drugmaker Salix Pharmaceuticals.

Ackman threatens to sue Allergan again over potential Salix deal

(Reuters) - Billionaire William Ackman's Pershing Square Capital Management said on Tuesday that it would sue botox-maker Allergan Inc if the company went ahead with a deal to buy drugmaker Salix Pharmaceuticals Ltd.

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy

September 24, 2014 by Brad Perriello

New U.S. Treasury rules on inversion deals are unlikely to scuttle Medtronic's pending $43 billion merger with Covidien, analysts say, but are likely to make it more complicated and expensive.

New inversion rules unlikely to scuttle Medtronic's $43B Covidien buy

Exec at MDT explains how COV gained $43B payout | The week in medtech M&A

September 24, 2014 by MassDevice

Here's a look at some of the top regulatory stories for medical device companies this week: Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together; Medtronic and Covidien prepare 1st Integration Summit; FTC approves Cerner's $1.3B Siemens health IT buy; Alere unveils $3.82B privatization plan; Medtronic, Covidien slide on new U.S. inversion rules

Inside the Medtronic-Covidien deal: Contrasting styles brought the companies together

September 17, 2014 by Brian Johnson

Zimmer and Biomet update on their mega-merger

September 24, 2014 by Arezu Sarvestani

Zimmer and Biomet provide updates following the 2nd in a series of "Integration Summits" where company leadership is fleshing out the details of their $13 billion merger.

Zimmer and Biomet update on their mega-merger

Leadership at Zimmer (NYSE:ZMH) and Biomet have been on merger overdrive in recent weeks, holding summits and hosting presentations as the companies navigate the tricky business of a $13 billion merger.

Philips to carve out lighting biz, merger healthcare & consumer units

September 23, 2014 by Alexander Soule

Royal Philips reveals plans to spin out its legacy lighting business and merge Philips Healthcare and its consumer business into a new 'HealthTech' unit.

Philips to carve out lighting biz, merger healthcare & consumer units

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp